Rare diseases
Investigational molecules
Locations
Back to Hungary164 clinical trials in Nyiregyhaza, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
HungaryStudy on Alnuctamab and Drug Combination for Patients with Relapsed or Refractory Multiple Myeloma
HungaryStudy on the Effectiveness and Safety of Finerenone for Adults with Non-Diabetic Chronic Kidney Disease
HungaryStudy on Tafasitamab and Lenalidomide with Standard Therapy for Newly Diagnosed High-Risk Diffuse Large B-Cell Lymphoma Patients
HungaryStudy Comparing Fedratinib with Drug Combination for Myelofibrosis in Patients Previously Treated with Ruxolitinib
HungaryStudy of Trastuzumab Deruxtecan with or without Pertuzumab for Patients with HER2-positive Metastatic Breast Cancer
HungaryStudy Comparing Pirtobrutinib to Bendamustine and Rituximab for Untreated Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
HungaryStudy on the Effectiveness of Enlicitide Chloride in Reducing Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease
HungaryStudy of Tamibarotene and Azacitidine Treatment in Newly Diagnosed Adults with RARA-positive Higher-risk Myelodysplastic Syndrome (MDS)
HungaryStudy on the Effectiveness and Safety of Gliclazide MR, Dapagliflozin, and Metformin for Patients with Type 2 Diabetes Not Well Controlled with Dapagliflozin
HungaryStudy on the Effects of AZD5462 for Patients with Stable Chronic Heart Failure
HungaryStudy on Extended Access to Momelotinib for Patients with Myelofibrosis
HungaryThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on breast cancer treatments, including studies for triple-negative and HR-positive/HER2-negative variants. Research extends to bladder cancer and lymphoma treatments.
Several studies are evaluating novel drug combinations and comparing their efficacy to standard treatments.
Comprehensive research into heart failure prevention and treatment of cardiovascular disease. Studies include innovative approaches for managing chronic conditions.
Trials are investigating new therapeutic combinations to improve patient outcomes in cardiovascular conditions.
Studies addressing chronic rhinosinusitis and respiratory infections, with particular focus on nasal polyps treatment and viral lung infections.
Research includes both preventive measures and therapeutic interventions for respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
